Clinical trial
Safety Study of MBP-426 (Liposomal Oxaliplatin Suspension for Injection) to…
NCT00355888 · Mebiopharm Co., Ltd, Industry · Completed
Key facts
| NCT number | NCT00355888 |
|---|---|
| Title | Safety Study of MBP-426 (Liposomal Oxaliplatin Suspension for Injection) to Treat Advanced or Metastatic Solid Tumors |
| Official title | A Phase I, Open Label Study of MBP-426 Given by Intravenous Infusion in Patients With Advanced or Metastatic Solid Tumors |
| Lead sponsor | Mebiopharm Co., Ltd, Industry |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Cancer |
| Intervention type | Drug |
| Interventions | MBP-426 |
| Enrollment | 39 |
| Start date | Jun 1, 2006 |
| Primary completion | Nov 1, 2008 |
| Completion | Apr 1, 2009 |
| First posted | Jul 25, 2006 |
| Last update posted | Dec 2, 2014 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: